Find out about PharmaDeals v2 (ISSN 1756-8390 – online database) subscriptions:
- Benefits to Your Company or Organisation
- PharmaDeals v2 Product Information
- Pricing and How to Order
Benefits to Your Company or Organisation
- Empower your business decision makers: Use information from PharmaDeals v2 to assist with mission-critical or high risk decisions
- Unrivalled benchmarking tool – intelligently indexed and compiled to international standards by the experts in deals and alliances
- Save time and cash: this is an outstanding research tool
- Track competitors' deal activities
- Analyse what is happening in your deal arena
- Quickly and cost-effectively access detailed industry intelligence, through PharmaDeals Review (ISSN 1756-7874 - online publication) included in your PharmaDeals v2 subscription
PharmaDeals v2 Product Information
As a subscriber to PharmaDeals®, you get effortless access to:
PharmaDeals Agreements:
- Our deals and alliances agreements database of over 29,000 deal records, which are continuously added to, updated and maintained by our specialist editorial team
- The database covers all territories, therapy areas and product stages of development, and allows immediate access to financials, to full-text contracts from US SEC filings, and to associated press materials
- An advanced search facility enables you to find and store the deals you need: You can search by therapeutic area, deal type (e.g. co-development, out-licensing); financial information, development phase (preclinical, Phase I,II, etc.), technology/product type (e.g. antibody, small molecule, assay, etc.), or any keyword.
- Intelligently Indexed: All deals are now classified according to: specific indications; territories can be searched by continent, region or individual country, giving you greater control over your searches; users can differentiate between therapeutic, diagnostic and technology deals to enable rapid and reliable analysis of the database
- Calendar of Events: Consult PharmaDeals to pre-screen potential partners before setting up meetings at upcoming partnering events
- Personalised Deal Alerts inform you of deals in your chosen areas of interest and are delivered straight to your mailbox
- Responsive Delivery: Subscribers to the PharmaDeals database can select several access options: Full Remote Access with password protection; Open Access within your company (IP Domain Authentication); XML feed – through special arrangement
- Our knowledgeable sales team will work with you to select the right delivery option for your company or organisation – contact us.
- New, Web 2.0-enabled user interface with a host of new features: Improved access and display; Browse related deals; Save deals to your watch list; Data can be exported and the graphing function enables you to illustrate your key findings in reports and presentations
- PharmaDeals Review, which offers expert analysis as deals occur, and includes an archive of in-depth review articles, a deal tracker, analyst opinion, and business commentaries on topical business and industry issues, and how they affect deal making
Pricing and How to Order
PharmaDeals v2: Agreements Database and Review
Agreements (ISSN 1756-8390 online database) and Review (ISSN 1756-7874 online publication) Anytime start.
Pricing: Complete our enquiry form and your Account Manager will work with you directly to find the best solution and pricing for your company or institution. Options include:
- Individual licenses
- Single or multi-site or global licenses
- One or multi-year subscriptions
- Access options include username/password, IP domain authentication (access through your company’s intranet) and xml data feed
PharmaDeals Review
ISSN 1756-7874, (online publication) Anytime start.
(Subscribers to PharmaDeals v2 receive PharmaDeals Review as part of their subscription.) Published by PharmaDeals, the publishing division of PharmaVentures Ltd. Pricing: £349 per calendar year subscription (based on one user, Review only).
Buy online now. or Complete our enquiry form to order your subscription for more than a single user or for further pricing options.